
Conagra is rated a Buy, with low investor expectations, conservative guidance, and visible turnaround catalysts supporting an attractive risk-reward profile. CAG's near-term margin pressure is offset by upcoming pricing actions, productivity gains, and targeted reinvestment in brands, supply chain, and innovation. Management's conservative FY27 volume outlook, especially for frozen, leaves room for upside as recent share gains and product velocity outpace assumptions.










